{"id":"https://openalex.org/W4200437806","doi":"https://doi.org/10.1016/j.annonc.2021.10.158","title":"139P First-in-human (FIH), pharmacokinetic (PK) and pharmacodynamic (PD) study of IOA-244, a phosphoinositide 3-kinase delta (PI3K\u03b4) inhibitor, in patients with advanced metastatic mesothelioma, uveal and cutaneous melanoma","display_name":"139P First-in-human (FIH), pharmacokinetic (PK) and pharmacodynamic (PD) study of IOA-244, a phosphoinositide 3-kinase delta (PI3K\u03b4) inhibitor, in patients with advanced metastatic mesothelioma, uveal and cutaneous melanoma","publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200437806","doi":"https://doi.org/10.1016/j.annonc.2021.10.158"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.10.158","doi":"https://doi.org/10.1016/j.annonc.2021.10.158","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.158","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2021.10.158","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107844545","display_name":"Anna Maria Di Giacomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134849","display_name":"Azienda Ospedaliera Universitaria Senese","ror":"https://ror.org/02s7et124","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134849"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A.M. Di Giacomo","raw_affiliation_strings":["U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy","institution_ids":["https://openalex.org/I4210134849"]}]},{"author_position":"middle","author":{"id":null,"display_name":"F. Santangelo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134849","display_name":"Azienda Ospedaliera Universitaria Senese","ror":"https://ror.org/02s7et124","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134849"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Santangelo","raw_affiliation_strings":["U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy","institution_ids":["https://openalex.org/I4210134849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049799323","display_name":"Giovanni Amato","orcid":"https://orcid.org/0009-0006-2843-6609","observed_orcids":["https://orcid.org/0009-0006-2843-6609"]},"institutions":[{"id":"https://openalex.org/I4210134849","display_name":"Azienda Ospedaliera Universitaria Senese","ror":"https://ror.org/02s7et124","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134849"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Amato","raw_affiliation_strings":["U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy","institution_ids":["https://openalex.org/I4210134849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054773035","display_name":"Elena Simonetti","orcid":"https://orcid.org/0009-0000-9647-4662","observed_orcids":["https://orcid.org/0009-0000-9647-4662"]},"institutions":[{"id":"https://openalex.org/I4210134849","display_name":"Azienda Ospedaliera Universitaria Senese","ror":"https://ror.org/02s7et124","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134849"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Simonetti","raw_affiliation_strings":["U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy","institution_ids":["https://openalex.org/I4210134849"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108512685","display_name":"Janet Graham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800201399","display_name":"NHS Greater Glasgow and Clyde","ror":"https://ror.org/05kdz4d87","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399"]},{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Graham","raw_affiliation_strings":["Medical Oncology Department, BWSCC - Beatson West of Scotland Cancer Centre - NHS Greater Glasgow and Clyde, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, BWSCC - Beatson West of Scotland Cancer Centre - NHS Greater Glasgow and Clyde, Glasgow, UK","institution_ids":["https://openalex.org/I2800201399","https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033549340","display_name":"Michael Lahn","orcid":"https://orcid.org/0000-0002-1377-7308","observed_orcids":["https://orcid.org/0000-0002-1377-7308"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M. Lahn","raw_affiliation_strings":["Oncology Department, iOnctura SA, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, iOnctura SA, Geneva, Switzerland","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111247453","display_name":"Rebeca Zorrilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. Zorilla","raw_affiliation_strings":["Oncology Department, iOnctura SA, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, iOnctura SA, Geneva, Switzerland","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091158700","display_name":"Lars van der Veen","orcid":"https://orcid.org/0000-0003-4525-0081","observed_orcids":["https://orcid.org/0000-0003-4525-0081"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"L. van der Veen","raw_affiliation_strings":["Oncology Department, iOnctura SA, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, iOnctura SA, Geneva, Switzerland","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076391983","display_name":"Zo\u00eb Johnson","orcid":"https://orcid.org/0000-0002-4120-2579","observed_orcids":["https://orcid.org/0000-0002-4120-2579"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Z. Johnson","raw_affiliation_strings":["Translational Research & Early Development, iOnctura SA, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research & Early Development, iOnctura SA, Geneva, Switzerland","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070849284","display_name":"Curtis R. Pickering","orcid":"https://orcid.org/0000-0002-7942-728X","observed_orcids":["https://orcid.org/0000-0002-7942-728X"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"C. Pickering","raw_affiliation_strings":["R&D Department, iOnctura SA, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Department, iOnctura SA, Geneva, Switzerland","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023917192","display_name":"Elisete Da Silva Marechal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Mar\u00e9chal","raw_affiliation_strings":["Biostatistics, LabCorp Clinical Development SARL, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, LabCorp Clinical Development SARL, Rueil-Malmaison, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Blanco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801558778","display_name":"LabCorp (United States)","ror":"https://ror.org/03zsdhz84","country_code":"US","type":"company","lineage":["https://openalex.org/I2801558778"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Blanco","raw_affiliation_strings":["Oncology, LabCorp Clinical and Periapproval Services Limited, Maidenhead, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, LabCorp Clinical and Periapproval Services Limited, Maidenhead, UK","institution_ids":["https://openalex.org/I2801558778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046509076","display_name":"Marco Durini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Durini","raw_affiliation_strings":["Oncology Department, LabCorp Clinical and Periapproval Services Limited, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, LabCorp Clinical and Periapproval Services Limited, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006932160","display_name":"Brandon T. Gufford","orcid":"https://orcid.org/0000-0002-4772-9638","observed_orcids":["https://orcid.org/0000-0002-4772-9638"]},"institutions":[{"id":"https://openalex.org/I2801558778","display_name":"LabCorp (United States)","ror":"https://ror.org/03zsdhz84","country_code":"US","type":"company","lineage":["https://openalex.org/I2801558778"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Gufford","raw_affiliation_strings":["Clinical Pharmacology, LabCorp, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, LabCorp, Madison, WI, USA","institution_ids":["https://openalex.org/I2801558778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037568604","display_name":"Tadepally Lakshmikanth","orcid":"https://orcid.org/0000-0001-7256-5770","observed_orcids":["https://orcid.org/0000-0001-7256-5770"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"T. Lakshmikanth","raw_affiliation_strings":["Women\u00b4s and Children\u00b4s Health, Karolinska Institutet, National Cellular Immunomonitoring Facility, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Women\u00b4s and Children\u00b4s Health, Karolinska Institutet, National Cellular Immunomonitoring Facility, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076200740","display_name":"Petter Brodin","orcid":"https://orcid.org/0000-0002-8103-0046","observed_orcids":["https://orcid.org/0000-0002-8103-0046"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"P. Brodin","raw_affiliation_strings":["Women\u00b4s and Children\u00b4s Health, Karolinska Institutet, National Cellular Immunomonitoring Facility, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Women\u00b4s and Children\u00b4s Health, Karolinska Institutet, National Cellular Immunomonitoring Facility, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033684622","display_name":"Pavlina Spiliopoulou","orcid":"https://orcid.org/0000-0002-6486-6319","observed_orcids":["https://orcid.org/0000-0002-6486-6319"]},"institutions":[{"id":"https://openalex.org/I2800201399","display_name":"NHS Greater Glasgow and Clyde","ror":"https://ror.org/05kdz4d87","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399"]},{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Spiliopoulou","raw_affiliation_strings":["Medical Oncology Department, BWSCC - Beatson West of Scotland Cancer Centre - NHS Greater Glasgow and Clyde, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, BWSCC - Beatson West of Scotland Cancer Centre - NHS Greater Glasgow and Clyde, Glasgow, UK","institution_ids":["https://openalex.org/I2800201399","https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109354205","display_name":"T. R. J. Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T.R.J. Evans","raw_affiliation_strings":["Institute of Cancer Sciences, University of Glasgow, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Sciences, University of Glasgow, Glasgow, UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018536695","display_name":"Michele Maio","orcid":"https://orcid.org/0000-0002-0323-6321","observed_orcids":["https://orcid.org/0000-0002-0323-6321"]},"institutions":[{"id":"https://openalex.org/I4210134849","display_name":"Azienda Ospedaliera Universitaria Senese","ror":"https://ror.org/02s7et124","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134849"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Maio","raw_affiliation_strings":["U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O.C. Immunoterapia Oncologica, Azienda Ospedaliera Universitaria Senese, Siena, Italy","institution_ids":["https://openalex.org/I4210134849"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.3994,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.57706478,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"32","issue":null,"first_page":"S1438","last_page":"S1438"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5932999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5932999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.16429999470710754,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7580000162124634},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cd63","display_name":"CD63","score":0.6349999904632568},{"id":"https://openalex.org/keywords/basophil-activation","display_name":"basophil activation","score":0.847000002861023},{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/mesothelioma","display_name":"mesothelioma","score":0.8619999885559082},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8579999804496765},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.5},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6510000228881836},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.6209999918937683},{"id":"https://openalex.org/keywords/biologically-effective-dose","display_name":"biologically effective dose","score":0.8309999704360962},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.7360000014305115},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.34700000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.847507119178772},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6379216313362122},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6240783333778381},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.5432326793670654},{"id":"https://openalex.org/C2779176990","wikidata":"https://www.wikidata.org/wiki/Q4867824","display_name":"Basophil activation","level":5,"score":0.5128858089447021},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5103203654289246},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5000572204589844},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4815680980682373},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4479401707649231},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44564497470855713},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.42095452547073364},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4115942120552063},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37348368763923645},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32531416416168213},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.27519288659095764},{"id":"https://openalex.org/C2777456892","wikidata":"https://www.wikidata.org/wiki/Q107988","display_name":"Basophil","level":4,"score":0.12693673372268677},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.1263228952884674},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.10.158","doi":"https://doi.org/10.1016/j.annonc.2021.10.158","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.158","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.10.158","doi":"https://doi.org/10.1016/j.annonc.2021.10.158","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.10.158","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281710573","https://openalex.org/W4283389496","https://openalex.org/W4311141718","https://openalex.org/W4323570108","https://openalex.org/W4308381593","https://openalex.org/W4307910031","https://openalex.org/W2954631920","https://openalex.org/W3083760081","https://openalex.org/W4379283389","https://openalex.org/W2983669389"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-12-31T00:00:00"}